Clinical Hospital Dr. Trifun Panovski

Bitola 7000

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Breast Neoplasm, Diabetes, Triple-Negative Breast Cancer, Triple-Negative Breast Neoplasms

Studies at this site

• Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC) — Stopped early
• ANDES-AGI-1067 as a Novel Antidiabetic Agent Evaluation Study — Status unconfirmed